May 04, 2022 / 09:00PM GMT
Operator
Thank you for standing by, and welcome to Allogene Therapeutics' First Quarter 2022 Conference Call. (Operator Instructions) Please be aware that today's call is being recorded. (Operator Instructions)
I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Please go ahead.
Christine Cassiano - Allogene Therapeutics, Inc. - Chief Communications Officer
Thank you, operator, and welcome to all who have joined this call. After the market closed today, Allogene issued a press release that provides a business update and financial results for the first quarter of 2022. This press release and today's webcast are both available on our website. As a reminder, for this call, we ask that all keep their questions to one per person.
Joining me on the call today are Dr. David Chang, President and Chief Executive Officer; Dr. Rafael Amado, Executive Vice President of Research and Development and Chief Medical Officer; and Dr. Eric Schmidt, Chief Financial Officer.
During today's call, we will be making certain
Q1 2022 Allogene Therapeutics Inc Earnings Call Transcript
May 05, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers